Comments

CareDx

CDNANASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$19.01
0.140.74%
At Close: -
$19.01
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Q2 2024 Earnings in 4 days from now on Wed Jul 31st, after the market close
Conference call scheduled in 4 days at 16:30 PM Click to view the webcast
CareDx (CDNA) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesGovernment TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$25.00
Lowest Price Target1
$15.00
Consensus Price Target1
$19.20

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

CareDx (NASDAQ:CDNA) Stock, Analyst Ratings, Price Targets, Forecasts

CareDx Inc has a consensus price target of $19.2 based on the ratings of 8 analysts. The high is $25 issued by BTIG on February 28, 2023. The low is $15 issued by Craig-Hallum on May 1, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, Craig-Hallum, and Goldman Sachs on July 17, 2024, May 17, 2024, and May 13, 2024, respectively. With an average price target of $17.33 between Goldman Sachs, Craig-Hallum, and Goldman Sachs, there's an implied -8.82% downside for CareDx Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
1
3
May
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Goldman Sachs
Craig-Hallum
Stephens & Co.
Craig-Hallum
BTIG

1calculated from analyst ratings

Analyst Ratings for CareDx

Buy NowGet Alert
07/17/2024Buy Now-15.83%Goldman Sachs
Matthew Sykes
$14 → $16MaintainsBuyGet Alert
05/31/2024Buy Now—HC Wainwright & Co.
Yi Chen
—Reiterates → NeutralGet Alert
05/17/2024Buy Now15.73%Craig-Hallum
Connor Chamberlain
$15 → $22MaintainsBuyGet Alert
05/15/2024Buy Now—HC Wainwright & Co.
Yi Chen
—Reiterates → NeutralGet Alert
05/13/2024Buy Now—Raymond James
Andrew Cooper
—DowngradeOutperform → Market PerformGet Alert
05/13/2024Buy Now-26.35%Goldman Sachs
Matthew Sykes
$10 → $14MaintainsBuyGet Alert
05/13/2024Buy Now-5.31%Stephens & Co.
Mason Carrico
$15 → $18MaintainsOverweightGet Alert
05/09/2024Buy Now-21.09%Craig-Hallum
Connor Chamberlain
 → $15ReiteratesBuy → BuyGet Alert
05/01/2024Buy Now-21.09%Craig-Hallum
Alexander Nowak
$12 → $15UpgradeHold → BuyGet Alert
04/17/2024Buy Now-21.09%Stephens & Co.
Mason Carrico
 → $15ReiteratesOverweight → OverweightGet Alert
11/09/2023Buy Now-47.4%Stephens & Co.
Mason Carrico
 → $10UpgradeEqual-Weight → OverweightGet Alert
09/26/2023Buy Now-47.4%Stephens & Co.
Mason Carrico
 → $10ReiteratesEqual-Weight → Equal-WeightGet Alert
08/15/2023Buy Now-36.88%Raymond James
Andrew Cooper
 → $12UpgradeMarket Perform → OutperformGet Alert
08/09/2023Buy Now—HC Wainwright & Co.
Yi Chen
—Reiterates → NeutralGet Alert
07/11/2023Buy Now—Raymond James
Andrew Cooper
—MaintainsMarket PerformGet Alert
05/11/2023Buy Now—BTIG
Sung Ji Nam
—DowngradeBuy → NeutralGet Alert
03/07/2023Buy Now-52.66%Stephens & Co.
Mason Carrico
$19 → $9DowngradeOverweight → Equal-WeightGet Alert
03/07/2023Buy Now-31.61%Goldman Sachs
Matthew Sykes
$25 → $13MaintainsBuyGet Alert
03/03/2023Buy Now-52.66%Craig-Hallum
Alexander Nowak
$26 → $9DowngradeBuy → HoldGet Alert
03/03/2023Buy Now26.25%Raymond James
Andrew Cooper
 → $24DowngradeStrong Buy → Market PerformGet Alert
02/28/2023Buy Now31.51%BTIG
Mark Massaro
$28 → $25MaintainsBuyGet Alert
02/28/2023Buy Now-0.05%Stephens & Co.
Mason Carrico
 → $19Reiterates → OverweightGet Alert
02/28/2023Buy Now36.77%Craig-Hallum
Alexander Nowak
$32 → $26MaintainsBuyGet Alert
02/28/2023Buy Now31.51%Goldman Sachs
Matthew Sykes
$29 → $25MaintainsBuyGet Alert
02/16/2023Buy Now-0.05%Stephens & Co.
Mason Carrico
 → $19Reiterates → OverweightGet Alert
02/06/2023Buy Now52.55%Goldman Sachs
Matthew Sykes
$40 → $29MaintainsBuyGet Alert
01/31/2023Buy Now26.25%Raymond James
Andrew Cooper
$26 → $24MaintainsStrong BuyGet Alert
11/08/2022Buy Now36.77%Raymond James
Andrew Cooper
$35 → $26MaintainsStrong BuyGet Alert
11/07/2022Buy Now47.29%BTIG
Mark Massaro
$37 → $28MaintainsBuyGet Alert
11/04/2022Buy Now110.42%Goldman Sachs
Matthew Sykes
$45 → $40MaintainsBuyGet Alert
08/10/2022Buy Now84.11%Raymond James
Andrew Cooper
$45 → $35MaintainsStrong BuyGet Alert
05/06/2022Buy Now136.72%Raymond James
Andrew Cooper
$52 → $45MaintainsStrong BuyGet Alert
04/25/2022Buy Now163.02%Stephens & Co.
Mason Carrico
 → $50Initiates → OverweightGet Alert
02/25/2022Buy Now173.54%Raymond James
Andrew Cooper
$90 → $52MaintainsStrong BuyGet Alert
10/29/2021Buy Now373.44%Raymond James
Andrew Cooper
—MaintainsStrong BuyGet Alert

FAQ

Q

What is the target price for CareDx (CDNA) stock?

A

The latest price target for CareDx (NASDAQ:CDNA) was reported by Goldman Sachs on July 17, 2024. The analyst firm set a price target for $16.00 expecting CDNA to fall to within 12 months (a possible -15.83% downside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for CareDx (CDNA)?

A

The latest analyst rating for CareDx (NASDAQ:CDNA) was provided by Goldman Sachs, and CareDx maintained their buy rating.

Q

When was the last upgrade for CareDx (CDNA)?

A

The last upgrade for CareDx Inc happened on May 1, 2024 when Craig-Hallum raised their price target to $15. Craig-Hallum previously had a hold for CareDx Inc.

Q

When was the last downgrade for CareDx (CDNA)?

A

The last downgrade for CareDx Inc happened on May 13, 2024 when Raymond James changed their price target from N/A to N/A for CareDx Inc.

Q

When is the next analyst rating going to be posted or updated for CareDx (CDNA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CareDx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CareDx was filed on July 17, 2024 so you should expect the next rating to be made available sometime around July 17, 2025.

Q

Is the Analyst Rating CareDx (CDNA) correct?

A

While ratings are subjective and will change, the latest CareDx (CDNA) rating was a maintained with a price target of $14.00 to $16.00. The current price CareDx (CDNA) is trading at is $19.01, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch